China online pharmaceutical trading site raises $16m
Yaoshibang, a Chinese B2B pharmaceutical trading platform, has raised a RMB110 million ($16 million) Series B round co-led by Shenzhen-based Green Pine Capital Partners and Fosun Group.
Existing investors Co-Power Capital and Ivy Capital also participated in the round. Operated by Guangzhou Speedroad Medical Information, Yaoshibang was launched in 2015 by a former executive at Chinese...
More on Greater China
Latest News
GGV to spin off Asia operation
GGV Capital’s Asia business will sever ties with the firm’s international operation – switching to separate partnerships and a distinct brand – as venture capital continues to feel the impact of the US and China’s conflicting technology agendas.
JIP-led consortium completes Toshiba tender offer
A consortium led by Japan Industrial Partners (JIP) has successfully completed a tender offer for Toshiba Corporation, paving the way for a JPY 2trn (USD 13.6bn) privatisation of the company.
Peak XV, Elevation, Andreessen back India visa platform
Peak XV Partners, formerly Sequoia Capital India, and Elevation Capital have led a USD 12m Series A round for Indian visa platform Atlys with support from Andreessen Horowitz.
Australia's PEP buys stake in biogas business from Sims
Pacific Equity Partners (PEP) has agreed to pay AUD 272.1m (USD 174m) for a 50% stake in LMS Energy, a biogas-to-energy and solar renewable energy business held by Australian metals recycler Sims.